Spurred by her past struggles with dissociative identity disorder, she has devoted her professional life to studying it.

Difficulty walking with MS is not just about physical limitations, but also emotions, stigma, and how others respond, a ...

New draft guidance from the FDA on multiple myeloma endpoints reflects the new technology available to assess disease and how patient journeys have changed with better treatments.

The rapid proliferation of high-efficacy disease-modifying therapies for multiple sclerosis (MS) has revolutionized the treatment landscape, yet significant gaps remain in how health systems organize ...